文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 高等教育 > 医学 > 2007:ESC:Guidelines on valvular heart disease
侵权投诉

2007:ESC:Guidelines on valvular heart disease

Guidelines on valvular heart disease

ESCGuidelinesTEEmaybeperformedtobetterde netheanatomyofthevalveandascendingaorta,especiallywhenvalve-sparinginterventionisconsidered.

Atthepresenttime,clinicaldecisionsshouldnotbebasedonchangesinEFonexercise,norondatafromstressecho-cardiographybecausetheseindices,althoughpotentiallyinteresting,havenotbeenadequatelyvalidated.

Whenavailable,MRIcanbeusedtoassesstheseverityofregurgitationandLVfunction,particularlywhenechocardio-graphicimagesareofpoorquality.

MRIorCTscanning,accordingtoavailabilityandexper-tise,isrecommendedfortheevaluationoftheaortainpatientswithanenlargedaortaasdetectedbyechocardio-graphy,especiallyincasesofbicuspidvalvesorMarfan’ssyndrome.

Naturalhistory

PatientswithacuteARhaveapoorprognosiswithoutinter-ventionowingtothesigni cantincreaseindiastolicLVpressure,leadingtopoorhaemodynamictolerance.ThereislittleinformationintheliteratureontheprogressionfrommildtosevereAR.PatientswithsevereARandsymp-tomshaveapoorprognosis.43

InasymptomaticpatientswithsevereARandnormalLVfunction,thenumberofeventsduringfollow-upislow:developmentofasymptomaticLVdysfunction,,1.3%peryear;suddendeath,,0.2%peryear;andsymptoms,LVimpairment,ordeath,4.3%peryear.Age,end-systolicdiameterorvolume,andEFatrestarepredictorsofoutcome.Onmultivariateanalysis,ageandend-systolicdiameter,whenitis.50mm,predictapooroutcome.43–46RecentdatasuggestthatitcouldbemoreappropriatetousethresholdsrelatedtoBSAandthepro-posedvalueisanend-systolicdiameter.25mm/m2BSA.42ThenaturalhistoryofaorticrootaneurysmhasbeenmainlystudiedinpatientswithMarfan’ssyndrome.ThestrongestpredictorsofcomplicationarethediameteroftheaorticrootatthelevelofthesinusesofValsalvaandthepresenceofafamilyhistoryofcardiovascularevents(aorticdissection,suddencardiacdeath).40,47–49Whentheaortahasreached6cminsize,yearlyratesofrupture,dis-section,anddeathare,respectively,3.6,3.7,and10.8%.Thereisarisingincidenceofdissectionorrupturewiththeincreaseinaneurysmsize.47–49Recentdatausingindexedvaluesshowa4,8,and.20%riskofcomplications,respectively,whenthemeasurementsare2.75,2.75–4.24,and.4.25cm/m2.41Patientswithbicuspidvalves50mayalsopresentarapidprogressionrate.Lessinformationisavailableforotheraetiologiessuchasannulo-aorticectasia.

Resultsofsurgery

SurgicaltreatmentofARisaorticvalvereplacementwhenthereisnoassociatedaorticaneurysm.Whenananeurysmoftheaorticrootisassociated,surgeryalsocomprisesrepla-cementoftheascendingaortawithre-implantationofthecoronaryarteries,combinedwitheitherreplacementofthevalveorvalve-sparingtechniques.Incurrentpractice,valvereplacementremainsthestandardandtheotherpro-ceduresareperformedinonlyasmallpercentageofpatients.Supra-coronaryreplacementofascendingaortacanbeperformedwhenValsalvasinusesarepreserved.

237

Table5Operativemortalityaftersurgeryforvalvularheart

disease

STSUKCSR

EHS(2001)

(1999–2000)(2001)Aorticvalve

3.7

3.1

2.7

replacement,noCABG(%)Aorticvalve6.374.3

replacementþCABG(%)Mitralvalve

2.22.80repair,noCABG(%)Mitralvalve

5.8

6.2

1.7

replacement,noCABG(%)

Mitralvalverepairor10.18.68.2

replacementþCABG(%)

CABG¼coronaryarterybypassgrafting.

STS¼SocietyofThoracicSurgeons(USA).MortalityforSTSincludes rstandredointerventions.51UKCSR¼UnitedKingdomCardiacSurgicalRegister.MortalityforUKCSRcorrespondsto rstinterventionsonly.52EHS¼EuroHeartSurvey.3CABG¼coronaryarterybypassgrafting.

Operativemortalityislow(1–3%)3,43,51,52(Table5)inasymptomaticpatientssubmittedtoisolatedaorticvalvesurgery.Insymptomaticpatients,inpatientswithcombinedaorticvalveandrootsurgery,andinpatientswithconcomitantcoronaryarterybypassgrafting(CABG),operativemortalityrangesfrom3to7%.Thestrongestpre-operativepredictorsofheartfailureordeathaftersurgeryareage,preoperativefunctionalclass,restingEF,50%orshorteningfraction,25%,andLVend-systolicdiameter.55mm.43–45,53–56

Immediateandlateresultsofthereplacementoftheascendingaorta,usingacompositegraft,areexcellentinMarfan’ssyndromewhenperformedbyexperiencedteamsonanelectivebasis.40,57Dataonconservativesurgeryaremorelimitedandcomefromexpertcentres.Insuchset-tings,recentserieshavereportedanoperativemortalityof1.6%,10yearsurvivalof88%,freedomfromaorticvalvereplacementof99%,andfreedomfromatleastmoderateARof83%.58,59

Indicationsforsurgery

InsymptomaticacuteAR,urgentinterventionisindicated.InchronicAR,thegoalsoftheoperationaretoimproveoutcome,todiminishsymptoms,topreventthedevelop-mentofpostoperativeheartfailureandcardiacdeath,andtoavoidaorticcomplicationsinpatientswhopresentwithaorticaneurysm.46,60

Onthebasisofrobustobservationalevidence,recom-mendedsurgicalindicationsareasfollows(Table6,Figure1):Symptomonsetisanindicationforsurgery.SurgeryshouldnotbedeniedinsymptomaticpatientswithLVdysfunctionormarkedLVdilatationaftercarefulexclusionofotherpossiblecauses.Althoughinthesepatientspostoperativeoutcomeisworsethaninpatientsoperatedatanearlierstage,acceptableoperativemortality,improvementof

上一页第8页

你可能喜欢

  • 外科诊疗常规
  • 心力衰竭课件
  • 感染性心内膜炎指南
  • 最全人体解剖图
  • 高血压PPT
  • 执业医师
  • 知情同意书

热门文档

相关文档

  • 心脏瓣膜病诊疗指南解读2

    Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...

  • 心脏瓣膜病诊疗指南解读1

    Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...

  • 重点!心脏瓣膜病诊疗指南解读

    2006年: ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease (美国) ? 2007年:ESC Guidelines on the Management of Valvular Heart...

  • Valvular_Heart_Disease_IM_8-12

    VALVULAR HEART DISEASE 52页 7下载券 Valvular Heart Disease 暂无评价 87页 1下载券 2007:ESC:Guidelines ... 39页 1下载券 A403-A418 Valvular Hea... 16...

  • 2014ESC-Revascularization

    No part of the ESC Guidelines may be translated or reproduced in any form..., Working Group on Thrombosis, Working Group on Valvular Heart Disease. ...

  • 2011ESC妊娠期心血管疾病诊疗指南

    10.1093/eurheartj/ehr218 ESC GUIDELINES ESC Guidelines on the management ...Valvular Heart Disease, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac...

  • 心力衰竭与感染

    Guidelines on the prevention, diagnosis, and ...(ESCMID) and the International Society of ...on valvular heart disease: focused update on ...

  • eurheartj.ehu281.full

    10.1093/eurheartj/ehu281 ESC GUIDELINES 2014 ESC Guidelines on the ...and Cardiac Computed Tomography, Peripheral Circulation, Valvular Heart Disease....

  • 2012ESC急慢性心衰治疗指南

    European Heart Journal doi:10.1093/eurheartj/ehs104 ESC GUIDELINES ESC ...Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...

  • 2012 ESC 心衰新指南(英文)

    Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...No part of the ESC Guidelines may be translated or reproduced in any form...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email